Shares of Intuitive Surgical (NASDAQ: ISRG) have taken a fall after a report by Andrew Left of Citron Research pegged shares of the stock at $350 in the near term and $250 over the next 18 months. But is the panic really merited? In this video, Motley Fool health care analysts Brenton Flynn and David Williamson go through some of the issues cited in the report and give their opinions on a few gray areas.
If you want exclusive, members-only analysis of the Citron report, be sure to check out this brand-new premium report on Intuitive Surgical. Only hours ago, analyst Karl Thiel released his take on the news, and it's only available here. As one of the minds behind our Rule Breakers recommendation of the stock in 2005 (before it went on to gain more than 1,000%), Thiel knows the Intuitive Surgical story inside and out. It's a must-read for any current or prospective investor, and it comes with a full year of analyst updates. Be sure to claim your copy today by clicking here now.
The article Is Intuitive Surgical Really in Trouble? originally appeared on Fool.com.
Brenton Flynn has no positions in the stocks mentioned above. David Williamson has no positions in the stocks mentioned above. The Motley Fool owns shares of Intuitive Surgical. Motley Fool newsletter services recommend Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.